Manufacturer of biodegradable bioplastics intended to offer polyhydroxyalkanoates (PHAs). The company offers novel fermentation technology to create bioplastics that biodegrade naturally within months, enabling industries to reduce waste and support a circular economy.

Developer of non-viral gene editing technology designed to improve cell and gene therapies.

Developer of a biotechnology platform designed to create multi-omics diagnostic assays for diabetes, Alzheimer’s, and other diseases. The company’s platform offers proteomics, metabolomics, and lipidomics analyses of small amounts of biological samples, including human plasma and mammalian cells, enabling doctors to empower mass spectrometry through integration and miniaturization.

Developer of ex vivo cell therapy technology designed for the expansion of T cells to support cancer treatment development. The company features engineered protein nanoparticles capable of conjugating multiple antibodies or cytokines, enhancing the quality and longevity of T cells, enabling research institutions and medical developers to advance cell therapy efficacy.

Modular Bionics is dedicated to delivering realized neurotechnologies. We develop and manufacture neurotechnology products for neuroscientists and clinical researchers.

Developer of modular therapeutic agents designed for targeted biological intervention. The company utilizes bio-inspired scaffolds with antibody-like potency, incorporates machine learning-guided molecular design, and emphasizes high stability and translatability across applications, enabling biomedical researchers and pharmaceutical developers enhanced precision, adaptability, and efficiency in addressing complex disease mechanisms and advancing next-generation treatment modalities.

A Next Generation Cell Therapy Company working towards a transplant of insulin producing cells combined with nanosensors for diabetes.